Pseudomembranous invasive tracheobronchial aspergillosis in an apparently immunocompetent patient with necrotizing pneumonia: a case report and brief review of the literature
Year: 2026
Type: article
Study design: Case Report
Abstract: Invasive tracheobronchial aspergillosis (ITBA) is a rare but life-threatening form of invasive pulmonary aspergillosis predominantly involving the tracheobronchial tree. Although commonly associated with immunocompromised states, ITBA has increasingly been reported in patients without classic host risk factors. Optimal treatment for refractory ITBA remains unclear. A 57-year-old woman presented with persistent fever, productive cough, pleuritic chest pain, wheezing, and respiratory failure after 12 days of treatment for Klebsiella pneumoniae pneumonia. She had no history of malignancy, transplantation, HIV infection, or chronic lung disease. Chest computed tomography revealed multifocal peribronchovascular consolidations with cavitary necrosis, diffuse bronchial wall thickening, and tree-in-bud nodules suggestive of invasive airway infection. Bronchoscopy demonstrated diffuse white pseudomembranes, friable mucosa, and purulent secretions throughout the tracheobronchial tree. Bronchoalveolar lavage microscopy showed filamentous fungi, and culture grew Aspergillus fumigatus . During initial antibacterial and oral voriconazole treatment, the patient remained dyspneic with high oxygen requirements despite declining inflammatory markers. Intravenous anidulafungin was added on hospital day 10 for suspected refractory ITBA. Clinical and radiological improvement subsequently occurred during concurrent antibacterial and combination antifungal treatment. The patient was discharged after 22 days and completed 20 weeks of voriconazole therapy. Follow-up CT showed further improvement. ITBA may occur in patients without recognized immunosuppressive conditions and should be considered in cases of invasive airway infection. Bronchoscopy is essential for early diagnosis, and combination therapy with voriconazole plus anidulafungin may be considered in selected patients with suspected refractory ITBA, although concurrent treatments limit interpretation of the response in this case.
Source: Egyptian Journal of Bronchology
Language: English
Subfield: Infectious Diseases
Field: Medicine
Domain: Health Sciences
Open Access status: diamond
OpenAlex ID: W7236034328
